AstraZeneca PLC

Stock Chart, Company Information, and Scan Results

$181.86(as of May 11, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

AstraZeneca PLC Company Information, Fundamentals, and Technical Indicators

Stock Price$181.86
Ticker SymbolAZN
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - General
Employees96,100
CountyUSA
Market Cap$283,469.3M
EBIDTA19,994.0M
10-Day Moving Average184.08
P/E Ratio27.33
20-Day Moving Average190.63
Forward P/E Ratio17.79
50-Day Moving Average193.29
Earnings per Share6.64
200-Day Moving Average177.19
Profit Margin20.15%
RSI35.73
Shares Outstanding1,550.3M
ATR3.84
52-Week High210.50
Volume2,012,059
52-Week Low130.04
Most Recent Support Level181.03
Book Value47,384.0M
Most Recent Resistance Level185.61
P/B Ratio5.99
Upper Keltner199.27
P/S Ratio4.70
Lower Keltner181.99
Debt-to-Equity Ratio199.27
Next Earnings DateUnknown
Cash Surplus-25,010.0M
Next Ex-Dividend DateUnknown

AstraZeneca is a Swedish-based pharmaceutical giant dedicated to discovering and developing innovative treatments for conditions like cancer and respiratory diseases. The company gained popularity during the novel COVID-19 pandemic with the development of viral vector vaccines to treat the virus. The company’s most popular product is Tagrisso—a medication used to treat lung carcinomas.

AstraZeneca PLC In Our Stock Scanner

As of May 12, 2026
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.